FIELD: medicine. SUBSTANCE: invention relates to treatment of pain syndrome in mastopathy, osteochondrosis, gastritis, colitis, neuritis of trigeminal, facial and sciatic nerves. Method involves the use of analgetic blockades with 4% of taufon that are carried out by intracutaneous administration of 2.0 ml of taufon at pain point for 10 days. EFFECT: enhanced effectiveness of analgesia, decreased pain relapse. 2 ex
Authors
Dates
2000-05-20—Published
1996-10-01—Filed